Literature DB >> 22571451

Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptor.

Francesco Piscitelli1, Alessia Ligresti, Giuseppe La Regina, Antonio Coluccia, Ludovica Morera, Marco Allarà, Ettore Novellino, Vincenzo Di Marzo, Romano Silvestri.   

Abstract

We synthesized new N-phenylethyl-1H-indole-2-carboxamides as the first SAR study of allosteric modulators of the CB(1) receptor. The presence of the carboxamide functionality was required in order to obtain a stimulatory effect. The maximum stimulatory activity on CB(1) was exerted by carboxamides 13 (EC(50) = 50 nM) and 21 (EC(50) = 90 nM) bearing a dimethylamino or piperidinyl group, respectively, at position 4 of the phenethyl moiety and a chlorine atom at position 5 of the indole.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22571451     DOI: 10.1021/jm201485c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  32 in total

1.  The membrane proximal region of the cannabinoid receptor CB1 N-terminus can allosterically modulate ligand affinity.

Authors:  Jonathan F Fay; David L Farrens
Journal:  Biochemistry       Date:  2013-11-08       Impact factor: 3.162

Review 2.  Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

Authors:  Robert P Picone; Debra A Kendall
Journal:  Mol Endocrinol       Date:  2015-04-13

3.  Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model.

Authors:  Robert B Laprairie; Amina M Bagher; Jillian L Rourke; Adel Zrein; Elizabeth A Cairns; Melanie E M Kelly; Christopher J Sinal; Pushkar M Kulkarni; Ganesh A Thakur; Eileen M Denovan-Wright
Journal:  Neuropharmacology       Date:  2019-03-30       Impact factor: 5.250

Review 4.  Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.

Authors:  Thuy Nguyen; Jun-Xu Li; Brian F Thomas; Jenny L Wiley; Terry P Kenakin; Yanan Zhang
Journal:  Med Res Rev       Date:  2016-11-23       Impact factor: 12.944

5.  Structure-activity relationship study of indole-2-carboxamides identifies a potent allosteric modulator for the cannabinoid receptor 1 (CB1).

Authors:  Mariam M Mahmoud; Hamed I Ali; Kwang H Ahn; Aparna Damaraju; Sushma Samala; Venkata K Pulipati; Srikanth Kolluru; Debra A Kendall; Dai Lu
Journal:  J Med Chem       Date:  2013-10-07       Impact factor: 7.446

Review 6.  Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain.

Authors:  Samuel D Banister; Kaavya Krishna Kumar; Vineet Kumar; Brian K Kobilka; Sanjay V Malhotra
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

Review 7.  Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.

Authors:  Ryan Wyrofsky; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Expert Opin Drug Discov       Date:  2014-12-09       Impact factor: 6.098

8.  Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018.

Authors:  Benjamin M Ford; Christian V Cabanlong; Sherrica Tai; Lirit N Franks; Narsimha R Penthala; Peter A Crooks; Paul L Prather; William E Fantegrossi
Journal:  J Pharmacol Exp Ther       Date:  2019-03-04       Impact factor: 4.030

9.  Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.

Authors:  Derek M Shore; Gemma L Baillie; Dow H Hurst; Frank Navas; Herbert H Seltzman; Jahan P Marcu; Mary E Abood; Ruth A Ross; Patricia H Reggio
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

10.  Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor.

Authors:  Kwang H Ahn; Mariam M Mahmoud; Sushma Samala; Dai Lu; Debra A Kendall
Journal:  J Neurochem       Date:  2013-01-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.